Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA): OK Quarter But Headwinds Reduce PT - Deutsche Bank

February 9, 2018 7:14 AM
Deutsche Bank analyst, Gregg Gilbert, reiterated his Hold rating on shares of Teva Pharma (NYSE: TEVA) and cut his price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles